Clinical Trials Logo

Clinical Trial Summary

This is an observational cohort study of clinical efficacy study.The purpose of this topic is to evaluate the efficacy and safety of Modified Liujunzi Decoction based on syndrome differentiation in patients with chronic atrophic gastritis(CAG) after HP eradication.Taking Modified Liujunzi Decoction as the observation group and Weifuchun routine treatment as the control group, so as to provide evidence for the treatment of CAG and reduce the risk of gastric cancer. A total of 284 patients were included. The curative efficacy, symptom score and adverse events will be recorded and analyzed.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05388890
Study type Observational
Source Peking University First Hospital
Contact Qiuyue Huang, doctor
Phone +86010 83572351
Email 1711210349@pku.edu.cn
Status Recruiting
Phase
Start date August 2, 2022
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06085677 - The Gastric HormonE BioMarkers of Preneoplastic Lesions Study
Completed NCT02955134 - The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis N/A
Active, not recruiting NCT05808010 - Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic Gastritis N/A
Terminated NCT01444014 - YF476 and Type I Gastric Carcinoids (Norway) Phase 2
Recruiting NCT05493124 - Clinical Study of Manpixiao in the Treatment of Chronic Atrophic Gastritis Early Phase 1
Completed NCT01339169 - YF476 and Type I Gastric Carcinoids Phase 2
Active, not recruiting NCT06267703 - Multi-omics Analyses on Etiology and Early Detection of Stomach Cancer Precursor Lesions
Recruiting NCT03597672 - Early Detection and Screening Strategy of Gatric Cancer in Sichuan Province-A Prospective Cohort Study (WCH-GC-SIGES-01)
Active, not recruiting NCT02782949 - Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia Phase 2